Oasmia Pharmaceutical AB
Oasmia receives a new MSEK 20 bank loan
Oasmia Pharmaceutical AB 30.12.2014 08:29 Dissemination of a Adhoc News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Uppsala, Sweden, 2014-12-30 08:29 CET (GLOBE NEWSWIRE) -- UPPSALA, SWEDEN - December 30, 2014. Oasmia Pharmaceutical AB (publ) announced today that it has received a new MSEK 20 bank loan. The loan replaces a previous MSEK 40 bank loan which is due on December 30, 2014. Anders Lundin, CFO Mobile: +46 70 209 63 00 E-mail: anders.lundin@oasmia.com News Source: NASDAQ OMX 30.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Oasmia Pharmaceutical AB Sweden Phone: Fax: E-mail: Internet: ISIN: SE0000722365 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden